Cizzle Biotechnology Holdings Plc (LON:CIZ)
London
· Delayed Price · Currency is GBP · Price in GBX 1.700
+0.150 (9.68%)
Mar 9, 2026, 3:55 PM GMT
Cizzle Biotechnology Holdings Company Description
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom.
It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology.
The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Cizzle Biotechnology Holdings Plc
| Country | United Kingdom |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
Contact Details
Address: The Shard London, SE1 9SG United Kingdom | |
| Phone | 44 203 9346630 |
| Website | cizzlebiotechnology.com |
Stock Details
| Ticker Symbol | CIZ |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB00BNG2VN02 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. Allan John Syms | Executive Chairman |
| Prof. Dawn Coverley | Founder, Chief Scientific Officer and Executive Director |
| Nigel R. Lee | Finance Director and Executive Director |